39 Results | Everything | Search

Product TypeClear Filters

Analytical Chemistry (3)

Biochemicals (39)

Antivirals (4)

Antioxidants (2)

Kinase Inhibitors (39)

Abl Family & Bcr-Abl (1)

Activin-like Kinases (ALKs) (1)

CaMKs (2)

EGFR/ErbB/HER Family (1)

FGFR Family (5)

LIMKs (3)

MEK (1)

p38 MAPK (2)

PDGFR Family (11)

RAF (39)

RET (5)

SRC Family (4)

Tie Family (4)

VEGFR Family (10)

Other Receptor Tyrosine Kinases (1)

Xenobiotic Metabolites (3)

Small Molecule Modulators (38)

Research AreaClear Filters

Cancer (38)

Cell Biology (5)

Immunology & Inflammation (4)

Infectious Disease (4)

Oxidative Stress & Reactive Species (4)

Xenobiotic Metabolism (3)

ApplicationClear Filters

Mass Spectrometry (3)

Displaying 1 - 25 of 39 Results

Sorafenib

A multi-kinase inhibitor

CAS No. 284461-73-0

Item No. 10009644

Formulation: A crystalline solid

Purity: ≥98%

BAY 43-9006

5 mg

$39

Add

10 mg

$59

Add

25 mg

$136

Add

50 mg

$231

Add

Dabrafenib

A Raf kinase inhibitor

CAS No. 1195765-45-7

Item No. 16989

Formulation: A crystalline solid

Purity: ≥98%

GSK2118436

5 mg

$42

Add

10 mg

$80

Add

50 mg

$209

Add

100 mg

$377

Add

Regorafenib

A multi-kinase inhibitor

CAS No. 755037-03-7

Item No. 18498

Formulation: A crystalline solid

Purity: ≥98%

BAY 73-4506

5 mg

$49

Add

10 mg

$93

Add

25 mg

$130

Add

50 mg

$236

Add

PLX4032

An inhibitor of mutant V600E and wild type B-Raf

CAS No. 918504-65-1

Item No. 10618

Formulation: A crystalline solid

Purity: ≥98%

RG-7204
Ro 51-85426
Vemurafenib

5 mg

$49

Add

10 mg

$77

Add

25 mg

$178

Add

50 mg

$329

Add

Encorafenib

An inhibitor of mutant B-Raf kinase

CAS No. 1269440-17-6

Item No. 16994

Formulation: A crystalline solid

Purity: ≥98%

LGX818

500 µg

$41

Add

1 mg

$77

Add

5 mg

$180

Add

PLX4720

An orally-available inhibitor of the B-raf mutant B-Raf^V600E

CAS No. 918505-84-7

Item No. 15142

Formulation: A crystalline solid

Purity: ≥95%

Raf Kinase Inhibitor V

1 mg

$49

Add

5 mg

$120

Add

10 mg

$152

Add

25 mg

$329

Add

GW 5074

A potent inhibitor of Raf-1

CAS No. 220904-83-6

Item No. 10010368

Formulation: A crystalline solid

Purity: ≥98% (mixture of cis and trans)

1 mg

$41

Add

5 mg

$128

Add

10 mg

$196

Add

25 mg

$437

Add

ZM 336372

An activator of the Raf-1 signalling pathway

CAS No. 208260-29-1

Item No. 10010367

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$48

Add

5 mg

$94

Add

10 mg

$160

Add

25 mg

$343

Add

LY3009120

A pan-Raf and Raf dimer inhibitor

CAS No. 1454682-72-4

Item No. 21504

Formulation: A crystalline solid

Purity: ≥98%

DP-4978

5 mg

$156

Add

10 mg

$279

Add

25 mg

$614

Add

50 mg

$1,077

Add

SB-590885

A potent inhibitor of B-Raf

CAS No. 405554-55-4

Item No. 16643

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$54

Add

5 mg

$132

Add

10 mg

$209

Add

25 mg

$458

Add

AZ 628

A Raf kinase inhibitor

CAS No. 878739-06-1

Item No. 15336

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$36

Add

5 mg

$103

Add

10 mg

$186

Add

25 mg

$420

Add

Sorafenib N-oxide

An active metabolite of sorafenib

CAS No. 583840-03-3

Item No. 27830

Formulation: A solid

Purity: ≥98%

BAY 67-3472

1 mg

$134

Add

5 mg

$432

Add

MLN2480

An oral pan-Raf kinase inhibitor

CAS No. 1096708-71-2

Item No. 19675

Formulation: A crystalline solid

Purity: ≥98%

BIIB-024
TAK-580
Tovorafenib

1 mg

$50

Add

5 mg

$137

Add

10 mg

$248

Add

25 mg

$557

Add

Belvarafenib

An inhibitor of B-RAF and C-RAF

CAS No. 1446113-23-0

Item No. 31460

Formulation: A crystalline solid

Purity: ≥98%

GDC-5573
HM95573

1 mg

$49

Add

5 mg

$167

Add

10 mg

$283

Add

25 mg

$469

Add

Sorafenib-d₃

An internal standard for the quantification of sorafenib

CAS No. 1130115-44-4

Item No. 34487

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₃)

BAY 43-9006-d₃

1 mg

$208

Add

5 mg

$932

Add

TAK-632

A selective pan-Raf inhibitor

CAS No. 1228591-30-7

Item No. 16285

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$36

Add

5 mg

$128

Add

10 mg

$186

Add

50 mg

$835

Add

CCT241161

A multi-kinase inhibitor

CAS No. 1163719-91-2

Item No. 25536

Formulation: A solid

Purity: ≥98%

500 µg

$75

Add

1 mg

$143

Add

5 mg

$553

Add

10 mg

$956

Add

BI-882370

A RAF inhibitor

CAS No. 1392429-79-6

Item No. 24273

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$36

Add

5 mg

$153

Add

10 mg

$268

Add

25 mg

$587

Add

Dabrafenib-d₉

An internal standard for the quantification of dabrafenib

CAS No. 1423119-98-5

Item No. 28797

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₉)

1 mg

$783

Add

RAF265

A B-Raf and VEGFR2 inhibitor

CAS No. 927880-90-8

Item No. 16991

Formulation: A crystalline solid

Purity: ≥98%

CHIR265

1 mg

$43

Add

5 mg

$183

Add

10 mg

$258

Add

25 mg

$483

Add

LXH254

A pan-RAF inhibitor

CAS No. 1800398-38-2

Item No. 28231

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$69

Add

5 mg

$297

Add

10 mg

$525

Add

25 mg

$901

Add

PLX7904

A RAF inhibitor

CAS No. 1393465-84-3

Item No. 20710

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$42

Add

5 mg

$183

Add

10 mg

$303

Add

25 mg

$653

Add

RAF709

A potent inhibitor of B-RAF and C-RAF

CAS No. 1628838-42-5

Item No. 23820

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$49

Add

5 mg

$190

Add

10 mg

$354

Add

Sorafenib (tosylate)

A multi-kinase inhibitor

CAS No. 475207-59-1

Item No. 35612

Formulation: A solid

Purity: ≥98%

BAY 43-9006 mono-p-tosylate
BAY 54-9085

5 g

$70

Add

10 g

$124

Add

25 g

$256

Add

50 g

$376

Add

GDC-0879

An inhibitor of B-Raf^V600E

CAS No. 905281-76-7

Item No. 16993

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$36

Add

5 mg

$128

Add

10 mg

$219

Add

25 mg

$502

Add

Displaying 1 - 25 of 39 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98% (mixture of cis and trans)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d3)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d9)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Purity: ≥99% deuterated forms (d₁-d₃)

Purity: ≥99% deuterated forms (d₁-d₉)